Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to ...

Upadacitinib vs ustekinumab reduced steroid use in TNF-exposed UC, with similar safety and clinical outcomes at 1 year.

Vitamin D supplementation is linked to less disease activity and inflammation in inflammatory bowel disease and may restore ...

Genetic risk for inflammatory bowel disease could also help identify which patients will have a more severe disease ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal pain and diarrhea. Although current treatments, including 5-aminosalicylic ...

Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory disorder of the colon that follows a relapsing-remitting course. Characterised by mucosal inflammation, the disease requires accurate ...

Medications are the foundation of treatment for moderate to severe ulcerative colitis (UC), with advanced therapies like JAK inhibitors, immunosuppressants, and biologics often playing a key role in ...

Switching your ulcerative colitis (UC) medication can help you manage the condition more effectively. But while your body adjusts, working and managing a family can be a major challenge. "Making a ...

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conventional treatment options or tumor necrosis factor ...

Landmark VIVID-2 data showed more than 90% of patients who achieved steroid-free remission at one year maintained steroid-free control through three years Additional new data revealed exceptionally ...